Haemonetics Corporation (HAE) SEC News Jan. 09, 2026, 11:17 UTC (90% Positive) HAEMONETICS CORPORATION (HAE) Provides Update on approval for pre-close Full text
Register to leave comments News bot Jan. 9, 2026, 11:19 a.m. 📋 HAEMONETICS CORPORATION (HAE) - Clinical Trial Update Filing Date: 2026-01-09 Accepted: 2026-01-09 06:17:23 Event Type: Clinical Trial Update Event Details: Haemonetics Corporation (HAE) Announces Clinical Trial Update Haemonetics Corporation (HAE) provided an update on its clinical development programs. Clinical Development Highlights: Drug Program: approval, needDiseases/Conditions: pre-close, percutaneous vessel closureCollaboration: PerQseal 🔬 Clinical Development Pipeline (HAEMONETICS CORPORATION): Product Type Development Stage Therapeutic Area Source BIO 300 Oral Suspension DRUG Phase PHASE1 Healthy Volunteer Study ClinicalTrials.gov Clopidogrel and proton pump inhibitors DRUG Phase PHASE4 30 Healthy People ClinicalTrials.gov OrthoPAT DEVICE Phase PHASE4 Osteoarthritis ClinicalTrials.gov Erythropoietin and drain device OTHER Phase PHASE4 Osteoarthritis ClinicalTrials.gov Erythropoietin and OrthoPAT OTHER Phase PHASE4 Osteoarthritis ClinicalTrials.gov Post-operative drain device DEVICE Phase PHASE4 Osteoarthritis ClinicalTrials.gov erythropoietin DRUG Phase PHASE4 Osteoarthritis ClinicalTrials.gov erythropoietin and cell saver OTHER Phase PHASE4 Osteoarthritis ClinicalTrials.gov OrthoPat Advance DEVICE Preclinical Transmission, Blood, Recipient/Donor ClinicalTrials.gov RapidTEG test PROCEDURE Preclinical Coagulopathy ClinicalTrials.gov Isotonic Saline DRUG Phase PHASE2 Postpartum Haemorrhage ClinicalTrials.gov Fibrinogen Concentrate DRUG Phase PHASE2 Postpartum Haemorrhage ClinicalTrials.gov BIO 300 Capsules DRUG Phase PHASE1 Acute Radiation Syndrome ClinicalTrials.gov Aspirin DRUG Phase PHASE4 Primary Total Hip and Knee Arthroplasty ClinicalTrials.gov Pneumatic compression stockings DEVICE Phase PHASE4 Primary Total Hip and Knee Arthroplasty ClinicalTrials.gov Arixtra DRUG Phase PHASE4 Primary Total Hip and Knee Arthroplasty ClinicalTrials.gov Placebo DRUG Phase PHASE2 Alzheimer's Disease ClinicalTrials.gov Drug: NIC5-15 DRUG Phase PHASE2 Alzheimer's Disease ClinicalTrials.gov 7-Keto Dehydroepiandrosterone DRUG Phase PHASE2 PTSD ClinicalTrials.gov Cilostazol 100mg DRUG Approved Coronary Heart Disease ClinicalTrials.gov Aspirin 100mg DRUG Approved Coronary Heart Disease ClinicalTrials.gov Clopidogrel 150mg DRUG Approved Coronary Heart Disease ClinicalTrials.gov Clopidogrel 75mg DRUG Approved Coronary Heart Disease ClinicalTrials.gov NIC5-15 DRUG Phase PHASE2 Alzheimer Disease ClinicalTrials.gov Blood product transfusion based on rapid thrombelastography (r-TEG) results. BIOLOGICAL Approved Acute Coagulopathy ClinicalTrials.gov Blood product transfusion based on conventional coagulation tests. BIOLOGICAL Approved Acute Coagulopathy ClinicalTrials.gov TEG6s DOAC Cartridge DEVICE Preclinical DOAC Eligible Subjects ClinicalTrials.gov Current Plasma Collection Approach DEVICE Approved Apheresis Related Hypotension ClinicalTrials.gov Updated Plasma Collection Feature DEVICE Approved Apheresis Related Hypotension ClinicalTrials.gov AS-3 (Control) DRUG Phase PHASE1 Blood Donors ClinicalTrials.gov SOLX (Investigational) DRUG Phase PHASE1 Blood Donors ClinicalTrials.gov Kawasumi (Needle Assembly) DEVICE Approved Transmission, Blood, Recipient/Donor ClinicalTrials.gov POLFA (Needle Assembly) DEVICE Approved Transmission, Blood, Recipient/Donor ClinicalTrials.gov Radiotherapy RADIATION Phase PHASE1 Carcinoma, Non-Small-Cell Lung ClinicalTrials.gov Carboplatin DRUG Phase PHASE1 Carcinoma, Non-Small-Cell Lung ClinicalTrials.gov Paclitaxel DRUG Phase PHASE1 Carcinoma, Non-Small-Cell Lung ClinicalTrials.gov BIO 300 Oral Powder DRUG Phase PHASE1 Acute Radiation Syndrome ClinicalTrials.gov 💼 Business Developments: Partnership: Not availableAcquisitionLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Haemonetics CorporationCIK: 0000313143Ticker Symbol: HAEPeriod End Date: 2026-01-09Document Type: 8-K
📋 HAEMONETICS CORPORATION (HAE) - Clinical Trial Update
Filing Date: 2026-01-09
Accepted: 2026-01-09 06:17:23
Event Type: Clinical Trial Update
Event Details:
🔬 Clinical Development Pipeline (HAEMONETICS CORPORATION):
💼 Business Developments:
Structured Data: